DENTSPLY SIRONA (NASDAQ:XRAY) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a hold rating to a buy rating in a research note released on Friday.

A number of other equities analysts have also commented on XRAY. Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Friday, August 8th. Barrington Research cut their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Stifel Nicolaus lowered their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday. Two research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $18.64.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $12.50 on Friday. The stock has a market capitalization of $2.49 billion, a price-to-earnings ratio of -2.64, a P/E/G ratio of 0.78 and a beta of 0.96. The firm’s 50-day moving average price is $14.14 and its two-hundred day moving average price is $14.81. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA has a 1-year low of $12.14 and a 1-year high of $27.44.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s revenue was down 4.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, equities analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.1%. DENTSPLY SIRONA’s dividend payout ratio is presently -13.50%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently modified their holdings of the business. Deutsche Bank AG boosted its stake in DENTSPLY SIRONA by 29.7% in the fourth quarter. Deutsche Bank AG now owns 15,720 shares of the medical instruments supplier’s stock valued at $298,000 after acquiring an additional 3,603 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of DENTSPLY SIRONA by 13.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier’s stock worth $10,466,000 after purchasing an additional 65,308 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of DENTSPLY SIRONA by 222.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 38,786 shares of the medical instruments supplier’s stock worth $736,000 after purchasing an additional 26,748 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of DENTSPLY SIRONA by 1,462.9% during the first quarter. GAMMA Investing LLC now owns 99,351 shares of the medical instruments supplier’s stock worth $1,484,000 after purchasing an additional 92,994 shares during the period. Finally, Merit Financial Group LLC bought a new stake in DENTSPLY SIRONA in the first quarter valued at about $548,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.